Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ADR-001 by Rohto Pharmaceutical for IgA Nephropathy (Berger's Disease): Likelihood of Approval
ADR-001 is under clinical development by Rohto Pharmaceutical and currently in Phase I for IgA Nephropathy (Berger's Disease). According to...